ESR1 and triple-negative breast carcinoma: The triple-negative breast cancer (TNBC) subtype is clinically defined by the absence of estrogen receptor (ER) and progesterone receptor (PR) expression and overexpression/amplification of human epidermal growth factor receptor 2 (HER2)2.